Related Experiment Video
Updated: Aug 7, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Proliferative glomerulonephritis and primary antiphospholipid syndrome
Abdalla H Abdalla1, Hala K Kfoury, Mohamed Al-Suleiman
1Department of Nephrology, Riyadh Medical Complex, Riyadh, Kingdom of Saudi Arabia.
Primary antiphospholipid syndrome (APLS) can cause proliferative glomerulonephritis (GN) through immune deposits, not just thrombotic microangiopathy. This case highlights a potential link in patients without lupus.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Primary antiphospholipid syndrome (APLS) is an autoimmune disorder.
- The association between APLS and proliferative glomerulonephritis (GN) is not well understood.
- Thrombotic microangiopathy (TMA) is a known renal manifestation of APLS.
Observation:
- A case of biopsy-documented primary APLS with proliferative GN is presented.
- The patient exhibited deep venous thrombosis, nephrotic syndrome, and a history of pregnancy complications.
- Absence of systemic lupus erythematosus (SLE) and TMA was noted.
Findings:
- Lupus anticoagulant was positive, confirming primary APLS diagnosis.
- Renal biopsy revealed membranoproliferative GN.
- The patient had persistent proteinuria but stable renal function over 12 years.
- Immune deposits were identified as the cause of GN, distinct from TMA.
Implications:
- Primary APLS can be associated with immune-mediated proliferative GN, independent of SLE or TMA.
- Further renal biopsies in APLS patients may reveal a higher prevalence of proliferative GN.
- This finding could inform future treatment strategies for APLS-related kidney disease.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Peripheral Artery Disease I: Introduction
Streptococcal Pharyngitis
Acute Kidney Injury II: Pathophysiology
Venous Thrombosis I: Introduction
Rheumatic Heart Disease I: Introduction

